Tanzanite Hematology-Oncology Pharmacy Elites (THOPE) is an innovative organisation based in Tanzania dedicated to advancing clinical pharmacy in haematology and oncology. With a strong focus on training, research, and consultancy, THOPE aims to enhance the knowledge and skills of healthcare professionals, ultimately improving patient care for patients with hematologic and oncologic conditions.
We provide comprehensive pharmaceutical care for patients with hematologic and oncologic conditions. Our goal is to improve outcomes through evidence-based practices, research, and collaboration, ensuring safe, effective medication use in a compassionate environment.
Our vision is to become a leader in haematology-oncology clinical pharmacy and antimicrobial stewardship for immunocompromised patients, focused on innovative care, education, and research. We aim to enhance patients' quality of life by incorporating the latest treatments and personalized strategies.
History
Established in 2018, our organisation was founded in response to the need for specialised clinical pharmacy services in the dynamic field of haematology and oncology. Through ongoing education and professional development, we have developed a robust foundation, continually incorporating the latest research findings to enhance patient care. Our team has expanded to meet the growing demands of this speciality, enabling us to broaden our service offerings accordingly. Established on this day of January 2025, Tanzanite Haematology/Oncology Pharmacy Elites has been officially registered in accordance with the Business Names (Registration) Act, holding Registration Number 595744, and operates from the United Republic of Tanzania. THOPE has successfully mentored over 500 mentees globally. Initially launched as the Pharmacozimbwe Mentorship and Coaching Program in 2018, it began as a WhatsApp group and public lectures and workshops, named after its founder, Zimbwe Kauke Bakari, a distinguished Tanzanian pharmacist specialising in haematology, oncology, bone marrow transplantation, and antimicrobial stewardship, with expertise in global health policy, guidelines, and protocol development.
Zimbwe has been instrumental in mentoring healthcare professionals across Tanzania in best practices for pharmacotherapy. In pursuit of institutionalisation and operationalisation, the program was rebranded to TANZANITE HAEMATOLOGY/ONCOLOGY PHARMACY ELITES (THOPE) in 2024, expanding its scope to encompass TRAINING | RESEARCH | CONSULTANCY, offering comprehensive Hematology-Oncology Clinical Pharmacy Practice and Basic and Advanced programs in Antimicrobial Stewardship.
Founded as the Pharmacozimbwe Mentorship and Coaching Program — WhatsApp group, public lectures, and workshops.
Rebranded to Tanzanite Haematology/Oncology Pharmacy Elites (THOPE) — TRAINING | RESEARCH | CONSULTANCY.
Officially registered (No. 595744); 500+ mentees mentored globally.
Core Values
Our primary focus is the well-being of our patients, guiding our decisions at every level.
We recognise the importance of teamwork, partnering closely with healthcare providers and patients to optimise treatment protocols.
We are committed to ongoing improvement, striving for the highest standards in clinical pharmacy practice and patient outcomes.
We are open to new ideas and methodologies, continuously enhancing our services and adapting to the evolving landscape of haematology-oncology and Antimicrobial Stewardship.
Our Team
Mentorship focus: Basic and Advanced Hematology-Oncology Clinical Pharmacy Practice; Basic and Advanced Antimicrobial Stewardship Programs in immunocompromised patients. Target audience: Pharmacists, Pharmaceutical Technicians and other health care professionals.

Founder & Lead Mentor
Haematology-Oncology, Infectious Diseases, Bone Marrow Transplantation Clinical PharmacistZimbwe Kauke Bakari is a distinguished clinical pharmacist whose expertise spans Haematology, Oncology, Bone Marrow Transplantation (BMT), and Infectious Diseases. He currently holds the position of Clinical Trials Control and Pharmacovigilance Officer at the Tanzania Medicines and Medical Devices Authority (TMDA). His remarkable career includes a previous role as the Chief Clinical Pharmacist and Assistant Director of the Pharmacy and Compounding Section at Benjamin Mkapa Hospital in Dodoma, Tanzania. During his time there, he made considerable advancements in clinical pharmacy, successfully initiating specialised oncology pharmacy services in 2020 and launching a Bone Marrow Transplant program in 2022.
Zimbwe’s clinical pharmacy background involves significant experience at the Ocean Road Cancer Institute (ORCI) as an oncology clinical pharmacist. Alongside this, he served as an Assistant Lecturer at three esteemed universities in Tanzania, where he imparts knowledge in pharmacology and clinical pharmacy to future pharmacists. He holds a Master’s degree in Hospital and Clinical Pharmacy and a Bachelor’s degree in Pharmacy, positioning him as a well-qualified professional in his field.
As a recipient of the Fleming Funds Fellowship Scheme, Zimbwe addresses the pressing issue of Antimicrobial Resistance (AMR). His advanced training from the St. Jude Global Academy’s Program on Global Infectious Diseases and Infection Control highlights his commitment to enhancing public health standards. In 2024, he embarked on a PhD fellowship focused on Antimicrobial Stewardship Programs in Tanzanian Paediatric Oncology Units, collaborating with the University of Antwerp in Belgium. His research is aimed at improving antibiotic use in pediatric cancer patients, thereby refining their treatment protocols and outcomes significantly.
In addition to his clinical efforts, Zimbwe plays a critical role in reviewing research protocols through Institutional Review Boards (IRBs) at various institutions, including Muhimbili University of Health and Allied Sciences (MUHAS) and the National Institute of Medical Research (NIMR). His contributions as an international peer reviewer span over seven journals, including notable publications such as BMC and BMJ. His work includes significant peer-reviewed publications and the development of vital protocols and guidelines, particularly with initiatives like the International Vaccine Institute’s "RADAAR Project: Advocacy to Drive AMR Policy: A Country Guide" published in 2023.
Zimbwe’s leadership extends to formulary development for both Benjamin Mkapa Hospital and Mirembe National Mental Health Hospital, signaling his unwavering dedication to quality healthcare delivery. His involvement in the sixth edition of the standard treatment guidelines, the Tanzania National Formulary templates, and the essential medicine policies illustrates his commitment to enhancing healthcare practices in Tanzania.
Internationally, Zimbwe actively contributes to the WHO Technical Advisory Group for AWaRe Antibiotics Categorisation and collaborates with the Commonwealth Pharmacists Association (CPA) AMR Curriculum Working Group. His dedication to pediatric oncology shines through his active participation with the International Society of Pediatric Oncology (SIOP), where he serves as Co-Chair of the SIOP Africa Oncology Pharmacy Working Group. His engagement extends to being the liaison for the European Society of Oncology Pharmacy Practitioners, highlighting his collaborative spirit in advancing pharmacy practices across borders.
Recognised for his contributions to paediatric oncology in Africa, Zimbwe received the Outstanding Leader accolade from the Young SIOP Network Leadership Assembly during the SIOP Global Congress in Honolulu, Hawaii, in 2024. He was further awarded the prestigious Pediatric Oncology Rising Star Award from the SIOP Africa Branch in Lagos, Nigeria, in 2026, which underscores his impact in mentoring oncology practitioners and strengthening pediatric pharmacy practices.
As the founder and lead mentor of The Tanzanite Haematology/Oncology Pharmacy Elites (THOPE), Zimbwe has guided over 200 professionals in oncology pharmacy and antimicrobial stewardship. His passion for advancing clinical pharmacy services goes hand-in-hand with his commitment to promoting health equity and universal health coverage, continually striving to enhance pediatric oncology in Africa through innovative education and specialised care.

Expert Mentor
Antimicrobial StewardshipMentors supporting basic and advanced programmes in antimicrobial stewardship and clinical pharmacy practices.
Clinical ICU Pharmacist | Commonwealth Pharmacists Association (CPA) Certified Mentor | Antimicrobial Stewardship (AMR) Advocate | Critical Care, Oncology & Internal Medicine| Superintendent Pharmacist – Hankil Medical Services Polyclinic.
Contact Us
Phone
+255683181747Headquarters
Dodoma, Tanzania
Registration
Registered under the Business Names (Registration) Act, United Republic of Tanzania — Registration Number 595744 (January 2025).
Tanzanite Haematology/Oncology Pharmacy Elites (THOPE)